Latest News & Updates

In the news | Medicamen Biotech Limited

Medicamen Biotech zooms by more than 16 per cent; do you own it?

MEDICAMEN BIOTECH LIMITED IS NOW NSE LISTED

Company is poised to launch novel oncology products in the FY 2021- 2022 in Indian region and South East Asian markets.

Haridwar Unit 1 for formulations is WHO GMP approved

ANDA filing for oncology formulations in process